<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39339934</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>13</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>AlphaFold2 Modeling and Molecular Dynamics Simulations of the Conformational Ensembles for the SARS-CoV-2 Spike Omicron JN.1, KP.2 and KP.3 Variants: Mutational Profiling of Binding Energetics Reveals Epistatic Drivers of the ACE2 Affinity and Escape Hotspots of Antibody Resistance.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1458</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v16091458</ELocationID><Abstract><AbstractText>The most recent wave of SARS-CoV-2 Omicron variants descending from BA.2 and BA.2.86 exhibited improved viral growth and fitness due to convergent evolution of functional hotspots. These hotspots operate in tandem to optimize both receptor binding for effective infection and immune evasion efficiency, thereby maintaining overall viral fitness. The lack of molecular details on structure, dynamics and binding energetics of the latest FLiRT and FLuQE variants with the ACE2 receptor and antibodies provides a considerable challenge that is explored in this study. We combined AlphaFold2-based atomistic predictions of structures and conformational ensembles of the SARS-CoV-2 spike complexes with the host receptor ACE2 for the most dominant Omicron variants JN.1, KP.1, KP.2 and KP.3 to examine the mechanisms underlying the role of convergent evolution hotspots in balancing ACE2 binding and antibody evasion. Using the ensemble-based mutational scanning of the spike protein residues and computations of binding affinities, we identified binding energy hotspots and characterized the molecular basis underlying epistatic couplings between convergent mutational hotspots. The results suggested the existence of epistatic interactions between convergent mutational sites at L455, F456, Q493 positions that protect and restore ACE2-binding affinity while conferring beneficial immune escape. To examine immune escape mechanisms, we performed structure-based mutational profiling of the spike protein binding with several classes of antibodies that displayed impaired neutralization against BA.2.86, JN.1, KP.2 and KP.3. The results confirmed the experimental data that JN.1, KP.2 and KP.3 harboring the L455S and F456L mutations can significantly impair the neutralizing activity of class 1 monoclonal antibodies, while the epistatic effects mediated by F456L can facilitate the subsequent convergence of Q493E changes to rescue ACE2 binding. Structural and energetic analysis provided a rationale to the experimental results showing that BD55-5840 and BD55-5514 antibodies that bind to different binding epitopes can retain neutralizing efficacy against all examined variants BA.2.86, JN.1, KP.2 and KP.3. The results support the notion that evolution of Omicron variants may favor emergence of lineages with beneficial combinations of mutations involving mediators of epistatic couplings that control balance of high ACE2 affinity and immune evasion.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Raisinghani</LastName><ForeName>Nishank</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-8562-4546</Identifier><AffiliationInfo><Affiliation>Keck Center for Science and Engineering, Graduate Program in Computational and Data Sciences, Schmid College of Science and Technology, Chapman University, Orange, CA 92866, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Structural Biology, Stanford University, Stanford, CA 94305, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alshahrani</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><Identifier Source="ORCID">0009-0002-3504-6386</Identifier><AffiliationInfo><Affiliation>Keck Center for Science and Engineering, Graduate Program in Computational and Data Sciences, Schmid College of Science and Technology, Chapman University, Orange, CA 92866, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>Grace</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Keck Center for Science and Engineering, Graduate Program in Computational and Data Sciences, Schmid College of Science and Technology, Chapman University, Orange, CA 92866, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verkhivker</LastName><ForeName>Gennady</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-4507-4471</Identifier><AffiliationInfo><Affiliation>Keck Center for Science and Engineering, Graduate Program in Computational and Data Sciences, Schmid College of Science and Technology, Chapman University, Orange, CA 92866, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical and Pharmaceutical Sciences, Chapman University School of Pharmacy, Irvine, CA 92618, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AI181600</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>NIH Award 1R01AI181600-01 and Subaward 6069-SC24-11</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>1R01AI181600-01A1</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.4.17.23</RegistryNumber><NameOfSubstance UI="C000705307">ACE2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.17.23</RegistryNumber><NameOfSubstance UI="D000085962">Angiotensin-Converting Enzyme 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D057134">Antibodies, Neutralizing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000657845">spike protein, SARS-CoV-2</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Organism" UI="C000711908">SARS-CoV-2 variants</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>bioRxiv. 2024 Jul 10:2024.07.09.602810. doi: 10.1101/2024.07.09.602810</RefSource><PMID Version="1">39026832</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000085962" MajorTopicYN="Y">Angiotensin-Converting Enzyme 2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057134" MajorTopicYN="N">Antibodies, Neutralizing</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004843" MajorTopicYN="N">Epistasis, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057131" MajorTopicYN="N">Immune Evasion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056004" MajorTopicYN="N">Molecular Dynamics Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="Y">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011487" MajorTopicYN="N">Protein Conformation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064370" MajorTopicYN="Y">Spike Glycoprotein, Coronavirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ACE2 host receptor</Keyword><Keyword MajorTopicYN="N">Omicron subvariants</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2 spike protein</Keyword><Keyword MajorTopicYN="N">binding energetics</Keyword><Keyword MajorTopicYN="N">epistasis</Keyword><Keyword MajorTopicYN="N">evolutionary mechanisms</Keyword><Keyword MajorTopicYN="N">immune escape</Keyword><Keyword MajorTopicYN="N">molecular dynamics</Keyword><Keyword MajorTopicYN="N">monoclonal antibodies</Keyword><Keyword MajorTopicYN="N">mutational scanning</Keyword><Keyword MajorTopicYN="N">network analysis</Keyword><Keyword MajorTopicYN="N">protein stability</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>29</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39339934</ArticleId><ArticleId IdType="pmc">PMC11437503</ArticleId><ArticleId IdType="doi">10.3390/v16091458</ArticleId><ArticleId IdType="pii">v16091458</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tai W., He L., Zhang X., Pu J., Voronin D., Jiang S., Zhou Y., Du L. Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: Implication for development of RBD protein as a viral attachment inhibitor and vaccine. Cell. Mol. Immunol. 2020;17:613–620. doi: 10.1038/s41423-020-0400-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-0400-4</ArticleId><ArticleId IdType="pmc">PMC7091888</ArticleId><ArticleId IdType="pubmed">32203189</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q., Zhang Y., Wu L., Niu S., Song C., Zhang Z., Lu G., Qiao C., Hu Y., Yuen K.Y., et al. Structural and functional basis of SARS-CoV-2 entry by using human ACE2. Cell. 2020;181:894–904.e9. doi: 10.1016/j.cell.2020.03.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.03.045</ArticleId><ArticleId IdType="pmc">PMC7144619</ArticleId><ArticleId IdType="pubmed">32275855</ArticleId></ArticleIdList></Reference><Reference><Citation>Walls A.C., Park Y.J., Tortorici M.A., Wall A., McGuire A.T., Veesler D. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell. 2020;181:281–292.e6. doi: 10.1016/j.cell.2020.02.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.058</ArticleId><ArticleId IdType="pmc">PMC7102599</ArticleId><ArticleId IdType="pubmed">32155444</ArticleId></ArticleIdList></Reference><Reference><Citation>Wrapp D., Wang N., Corbett K.S., Goldsmith J.A., Hsieh C.L., Abiona O., Graham B.S., McLellan J.S. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367:1260–1263. doi: 10.1126/science.abb2507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb2507</ArticleId><ArticleId IdType="pmc">PMC7164637</ArticleId><ArticleId IdType="pubmed">32075877</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai Y., Zhang J., Xiao T., Peng H., Sterling S.M., Walsh R.M., Jr., Rawson S., Rits-Volloch S., Chen B. Distinct conformational states of SARS-CoV-2 spike protein. Science. 2020;369:1586–1592. doi: 10.1126/science.abd4251.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd4251</ArticleId><ArticleId IdType="pmc">PMC7464562</ArticleId><ArticleId IdType="pubmed">32694201</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsieh C.L., Goldsmith J.A., Schaub J.M., DiVenere A.M., Kuo H.C., Javanmardi K., Le K.C., Wrapp D., Lee A.G., Liu Y., et al. Structure-based design of prefusion-stabilized SARS-CoV-2 spikes. Science. 2020;369:1501–1505. doi: 10.1126/science.abd0826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd0826</ArticleId><ArticleId IdType="pmc">PMC7402631</ArticleId><ArticleId IdType="pubmed">32703906</ArticleId></ArticleIdList></Reference><Reference><Citation>Henderson R., Edwards R.J., Mansouri K., Janowska K., Stalls V., Gobeil S.M.C., Kopp M., Li D., Parks R., Hsu A.L., et al. Controlling the SARS-CoV-2 spike glycoprotein conformation. Nat. Struct. Mol. Biol. 2020;27:925–933. doi: 10.1038/s41594-020-0479-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-020-0479-4</ArticleId><ArticleId IdType="pmc">PMC8581954</ArticleId><ArticleId IdType="pubmed">32699321</ArticleId></ArticleIdList></Reference><Reference><Citation>McCallum M., Walls A.C., Bowen J.E., Corti D., Veesler D. Structure-guided covalent stabilization of coronavirus spike glycoprotein trimers in the closed conformation. Nat. Struct. Mol. Biol. 2020;27:942–949. doi: 10.1038/s41594-020-0483-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-020-0483-8</ArticleId><ArticleId IdType="pmc">PMC7541350</ArticleId><ArticleId IdType="pubmed">32753755</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong X., Qu K., Ciazynska K.A., Hosmillo M., Carter A.P., Ebrahimi S., Ke Z., Scheres S.H.W., Bergamaschi L., Grice G.L., et al. A thermostable, closed SARS-CoV-2 spike protein trimer. Nat. Struct. Mol. Biol. 2020;27:934–941. doi: 10.1038/s41594-020-0478-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-020-0478-5</ArticleId><ArticleId IdType="pmc">PMC7116388</ArticleId><ArticleId IdType="pubmed">32737467</ArticleId></ArticleIdList></Reference><Reference><Citation>Costello S.M., Shoemaker S.R., Hobbs H.T., Nguyen A.W., Hsieh C.L., Maynard J.A., McLellan J.S., Pak J.E., Marqusee S. The SARS-CoV-2 spike reversibly samples an open-trimer conformation exposing novel epitopes. Nat. Struct. Mol. Biol. 2022;27:229–238. doi: 10.1038/s41594-022-00735-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-022-00735-5</ArticleId><ArticleId IdType="pmc">PMC9007726</ArticleId><ArticleId IdType="pubmed">35236990</ArticleId></ArticleIdList></Reference><Reference><Citation>McCormick K.D., Jacobs J.L., Mellors J.W. The emerging plasticity of SARS-CoV-2. Science. 2021;371:1306–1308. doi: 10.1126/science.abg4493.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abg4493</ArticleId><ArticleId IdType="pubmed">33766871</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghimire D., Han Y., Lu M. Structural Plasticity and Immune Evasion of SARS-CoV-2 Spike Variants. Viruses. 2022;14:1255. doi: 10.3390/v14061255.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14061255</ArticleId><ArticleId IdType="pmc">PMC9229035</ArticleId><ArticleId IdType="pubmed">35746726</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu C., Wang Y., Liu C., Zhang C., Han W., Hong X., Wang Y., Hong Q., Wang S., Zhao Q., et al. Conformational dynamics of SARS-CoV-2 trimeric spike glycoprotein in complex with receptor ACE2 revealed by cryo-EM. Sci. Adv. 2021;7:eabe5575. doi: 10.1126/sciadv.abe5575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abe5575</ArticleId><ArticleId IdType="pmc">PMC7775788</ArticleId><ArticleId IdType="pubmed">33277323</ArticleId></ArticleIdList></Reference><Reference><Citation>Benton D.J., Wrobel A.G., Xu P., Roustan C., Martin S.R., Rosenthal P.B., Skehel J.J., Gamblin S.J. Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion. Nature. 2020;588:327–330. doi: 10.1038/s41586-020-2772-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2772-0</ArticleId><ArticleId IdType="pmc">PMC7116727</ArticleId><ArticleId IdType="pubmed">32942285</ArticleId></ArticleIdList></Reference><Reference><Citation>Turoňová B., Sikora M., Schuerman C., Hagen W.J.H., Welsch S., Blanc F.E.C., von Bülow S., Gecht M., Bagola K., Hörner C., et al. In situ structural analysis of SARS-CoV-2 spike reveals flexibility mediated by three hinges. Science. 2020;370:203–208. doi: 10.1126/science.abd5223.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd5223</ArticleId><ArticleId IdType="pmc">PMC7665311</ArticleId><ArticleId IdType="pubmed">32817270</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu M., Uchil P.D., Li W., Zheng D., Terry D.S., Gorman J., Shi W., Zhang B., Zhou T., Ding S., et al. Real-time conformational dynamics of SARS-CoV-2 spikes on virus particles. Cell Host Microbe. 2020;28:880–891.e8. doi: 10.1016/j.chom.2020.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.11.001</ArticleId><ArticleId IdType="pmc">PMC7664471</ArticleId><ArticleId IdType="pubmed">33242391</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z., Han Y., Ding S., Shi W., Zhou T., Finzi A., Kwong P.D., Mothes W., Lu M. SARS-CoV-2 Variants Increase Kinetic Stability of Open Spike Conformations as an Evolutionary Strategy. mBio. 2022;13:e0322721. doi: 10.1128/mbio.03227-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mbio.03227-21</ArticleId><ArticleId IdType="pmc">PMC8844933</ArticleId><ArticleId IdType="pubmed">35164561</ArticleId></ArticleIdList></Reference><Reference><Citation>Díaz-Salinas M.A., Li Q., Ejemel M., Yurkovetskiy L., Luban J., Shen K., Wang Y., Munro J.B. Conformational dynamics and allosteric modulation of the SARS-CoV-2 spike. Elife. 2022;11:e75433. doi: 10.7554/eLife.75433.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.75433</ArticleId><ArticleId IdType="pmc">PMC8963877</ArticleId><ArticleId IdType="pubmed">35323111</ArticleId></ArticleIdList></Reference><Reference><Citation>Parums D.V. Editorial: The XBB.1.5 (‘Kraken’) Subvariant of Omicron SARS-CoV-2 and its Rapid Global Spread. Med. Sci. Monit. 2023;29:e939580. doi: 10.12659/MSM.939580.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.939580</ArticleId><ArticleId IdType="pmc">PMC9901170</ArticleId><ArticleId IdType="pubmed">36722047</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q., Iketani S., Li Z., Liu L., Guo Y., Huang Y., Bowen A.D., Liu M., Wang M., Yu J., et al. Alarming Antibody Evasion Properties of Rising SARS-CoV-2 BQ and XBB Subvariants. Cell. 2023;186:279–286.e8. doi: 10.1016/j.cell.2022.12.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.12.018</ArticleId><ArticleId IdType="pmc">PMC9747694</ArticleId><ArticleId IdType="pubmed">36580913</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M., Arora P., Nehlmeier I., Kempf A., Cossmann A., Schulz S.R., Morillas Ramos G., Manthey L.A., Jäck H.-M., Behrens G.M.N., et al. Profound Neutralization Evasion and Augmented Host Cell Entry Are Hallmarks of the Fast-Spreading SARS-CoV-2 Lineage XBB.1.5. Cell. Mol. Immunol. 2023;20:419–422. doi: 10.1038/s41423-023-00988-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-023-00988-0</ArticleId><ArticleId IdType="pmc">PMC9982771</ArticleId><ArticleId IdType="pubmed">36869193</ArticleId></ArticleIdList></Reference><Reference><Citation>Starr T.N., Greaney A.J., Hilton S.K., Ellis D., Crawford K.H.D., Dingens A.S., Navarro M.J., Bowen J.E., Tortorici M.A., Walls A.C., et al. Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding. Cell. 2020;182:1295–1310.e20. doi: 10.1016/j.cell.2020.08.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.08.012</ArticleId><ArticleId IdType="pmc">PMC7418704</ArticleId><ArticleId IdType="pubmed">32841599</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadfield J., Megill C., Bell S.M., Huddleston J., Potter B., Callender C., Sagulenko P., Bedford T., Neher R.A. Nextstrain: Real-Time Tracking of Pathogen Evolution. Bioinformatics. 2018;34:4121–4123. doi: 10.1093/bioinformatics/bty407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bty407</ArticleId><ArticleId IdType="pmc">PMC6247931</ArticleId><ArticleId IdType="pubmed">29790939</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamasoba D., Uriu K., Plianchaisuk A., Kosugi Y., Pan L., Zahradnik J., Ito J., Sato K. Virological Characteristics of the SARS-CoV-2 Omicron XBB.1.16 Variant. Lancet Infect. Dis. 2023;23:655–656. doi: 10.1016/S1473-3099(23)00278-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00278-5</ArticleId><ArticleId IdType="pmc">PMC10156138</ArticleId><ArticleId IdType="pubmed">37148902</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsujino S., Deguchi S., Nomai T., Padilla-Blanco M., Plianchaisuk A., Wang L., Begum M.M., Uriu K., Mizuma K., Nao N., et al. Virological Characteristics of the SARS-CoV-2 Omicron EG.5.1 Variant. Microbiol. Immunol. 2024;68:305–330. doi: 10.1111/1348-0421.13165.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1348-0421.13165</ArticleId><ArticleId IdType="pubmed">38961765</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q., Guo Y., Zhang R.M., Ho J., Mohri H., Valdez R., Manthei D.M., Gordon A., Liu L., Ho D.D. Antibody Neutralization of Emerging SARS-CoV-2 Subvariants: EG.5.1 and XBC.1.6. Lancet Infect. Dis. 2023;23:e397–e398. doi: 10.1016/S1473-3099(23)00555-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00555-8</ArticleId><ArticleId IdType="pubmed">37708906</ArticleId></ArticleIdList></Reference><Reference><Citation>Faraone J.N., Qu P., Goodarzi N., Zheng Y.-M., Carlin C., Saif L.J., Oltz E.M., Xu K., Jones D., Gumina R.J., et al. Immune Evasion and Membrane Fusion of SARS-CoV-2 XBB Subvariants EG.5.1 and XBB.2.3. Emerg. Microbes Infect. 2023;12:2270069. doi: 10.1080/22221751.2023.2270069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2023.2270069</ArticleId><ArticleId IdType="pmc">PMC10606793</ArticleId><ArticleId IdType="pubmed">37819267</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosugi Y., Plianchaisuk A., Putri O., Uriu K., Kaku Y., Hinay A.A., Jr., Chen L., Kuramochi J., Sadamasu K., Yoshimura K., et al. Characteristics of the SARS-CoV-2 Omicron HK.3 Variant Harbouring the FLip Substitution. Lancet Microbe. 2024;5:e313. doi: 10.1016/S2666-5247(23)00373-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(23)00373-7</ArticleId><ArticleId IdType="pubmed">38219759</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q., Guo Y., Liu L., Schwanz L.T., Li Z., Nair M.S., Ho J., Zhang R.M., Iketani S., Yu J., et al. Antigenicity and Receptor Affinity of SARS-CoV-2 BA.2.86 Spike. Nature. 2023;624:639–644. doi: 10.1038/s41586-023-06750-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-06750-w</ArticleId><ArticleId IdType="pubmed">37871613</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang S., Yu Y., Jian F., Song W., Yisimayi A., Chen X., Xu Y., Wang P., Wang J., Yu L., et al. Antigenicity and Infectivity Characterization of SARS-CoV-2 BA.2.86. Lancet Infect. Dis. 2023;23:e457–e459. doi: 10.1016/S1473-3099(23)00573-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00573-X</ArticleId><ArticleId IdType="pubmed">37738994</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamura T., Mizuma K., Nasser H., Deguchi S., Padilla-Blanco M., Oda Y., Uriu K., Tolentino J.E.M., Tsujino S., Suzuki R., et al. Virological Characteristics of the SARS-CoV-2 BA.2.86 Variant. Cell Host Microbe. 2024;32:170–180.e12. doi: 10.1016/j.chom.2024.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2024.01.001</ArticleId><ArticleId IdType="pubmed">38280382</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C., Zhou D., Dijokaite-Guraliuc A., Supasa P., Duyvesteyn H.M.E., Ginn H.M., Selvaraj M., Mentzer A.J., Das R., de Silva T.I., et al. A Structure-Function Analysis Shows SARS-CoV-2 BA.2.86 Balances Antibody Escape and ACE2 Affinity. Cell Rep. Med. 2024;5:101553. doi: 10.1016/j.xcrm.2024.101553.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2024.101553</ArticleId><ArticleId IdType="pmc">PMC11148769</ArticleId><ArticleId IdType="pubmed">38723626</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan K., Lustig G., Römer C., Reedoy K., Jule Z., Karim F., Ganga Y., Bernstein M., Baig Z., Jackson L., et al. Evolution and Neutralization Escape of the SARS-CoV-2 BA.2.86 Subvariant. Nat. Commun. 2023;14:8078. doi: 10.1038/s41467-023-43703-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-43703-3</ArticleId><ArticleId IdType="pmc">PMC10700484</ArticleId><ArticleId IdType="pubmed">38057313</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang S., Yu Y., Xu Y., Jian F., Song W., Yisimayi A., Wang P., Wang J., Liu J., Yu L., et al. Fast Evolution of SARS-CoV-2 BA.2.86 to JN.1 under Heavy Immune Pressure. Lancet Infect. Dis. 2024;24:e70–e72. doi: 10.1016/S1473-3099(23)00744-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00744-2</ArticleId><ArticleId IdType="pubmed">38109919</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaku Y., Okumura K., Padilla-Blanco M., Kosugi Y., Uriu K., Hinay A.A., Jr., Chen L., Plianchaisuk A., Kobiyama K., Ishii K.J., et al. Virological Characteristics of the SARS-CoV-2 JN.1 Variant. Lancet Infect. Dis. 2024;24:e82. doi: 10.1016/S1473-3099(23)00813-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00813-7</ArticleId><ArticleId IdType="pubmed">38184005</ArticleId></ArticleIdList></Reference><Reference><Citation>Li P., Faraone J.N., Hsu C.C., Chamblee M., Zheng Y.M., Carlin C., Bednash J.S., Horowitz J.C., Mallampalli R.K., Saif L.J., et al. Neutralization escape, infectivity, and membrane fusion of JN.1-derived SARS-CoV-2 SLip, FLiRT, and KP.2 variants. Cell Rep. 2024;43:114520. doi: 10.1016/j.celrep.2024.114520.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2024.114520</ArticleId><ArticleId IdType="pmc">PMC11430188</ArticleId><ArticleId IdType="pubmed">39024099</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu P., Faraone J.N., Evans J.P., Zheng Y.-M., Carlin C., Anghelina M., Stevens P., Fernandez S., Jones D., Panchal A.R., et al. Enhanced Evasion of Neutralizing Antibody Response by Omicron XBB.1.5, CH.1.1, and CA.3.1 Variants. Cell Rep. 2023;42:112443. doi: 10.1016/j.celrep.2023.112443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2023.112443</ArticleId><ArticleId IdType="pmc">PMC10279473</ArticleId><ArticleId IdType="pubmed">37104089</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaku Y., Uriu K., Kosugi Y., Okumura K., Yamasoba D., Uwamino Y., Kuramochi J., Sadamasu K., Yoshimura K., Asakura H., et al. Virological Characteristics of the SARS-CoV-2 KP.2 Variant. Lancet Infect. Dis. 2024;24:e416. doi: 10.1016/S1473-3099(24)00298-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(24)00298-6</ArticleId><ArticleId IdType="pubmed">38782005</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaku Y., Yo M.S., Tolentino J.E., Uriu K., Okumura K., Ito J., Sato K. Virological Characteristics of the SARS-CoV-2 KP.3, LB.1, and KP.2.3 Variants. Lancet Infect. Dis. 2024;24:e482–e483. doi: 10.1016/S1473-3099(24)00415-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(24)00415-8</ArticleId><ArticleId IdType="pubmed">38945150</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q., Mellis I.A., Ho J., Bowen A., Kowalski-Dobson T., Valdez R., Katsamba P.S., Wu M., Lee C., Shapiro L., et al. Recurrent SARS-CoV-2 spike mutations confer growth advantages to select JN.1 sublineages. Emerg Microbes Infect. 2024;11:2402880. doi: 10.1080/22221751.2024.2402880.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2024.2402880</ArticleId><ArticleId IdType="pmc">PMC11407393</ArticleId><ArticleId IdType="pubmed">39259045</ArticleId></ArticleIdList></Reference><Reference><Citation>Soudani N., Bricker T.L., Darling T., Seehra K., Patel N., Guebre-Xabier M., Smith G., Davis-Gardner M., Suthar M.S., Ellebedy A.H., et al. Immunogenicity and efficacy of XBB.1.5 rS vaccine against the EG.5.1 variant of SARS-CoV-2 in Syrian hamsters. J. Virol. 2024:e0052824. doi: 10.1128/jvi.00528-24.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00528-24</ArticleId><ArticleId IdType="pubmed">39230305</ArticleId></ArticleIdList></Reference><Reference><Citation>Dadonaite B., Brown J., McMahon T.E., Farrell A.G., Figgins M.D., Asarnow D., Stewart C., Lee J., Logue J., Bedford T., et al. Spike deep mutational scanning helps predict success of SARS-CoV-2 clades. Nature. 2024;631:617–626. doi: 10.1038/s41586-024-07636-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-024-07636-1</ArticleId><ArticleId IdType="pmc">PMC11254757</ArticleId><ArticleId IdType="pubmed">38961298</ArticleId></ArticleIdList></Reference><Reference><Citation>Starr T.N., Greaney A.J., Stewart C.M., Walls A.C., Hannon W.W., Veesler D., Bloom J.D. Deep Mutational Scans for ACE2 Binding, RBD Expression, and Antibody Escape in the SARS-CoV-2 Omicron BA.1 and BA.2 Receptor-Binding Domains. PLoS Pathog. 2022;18:e1010951. doi: 10.1371/journal.ppat.1010951.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1010951</ArticleId><ArticleId IdType="pmc">PMC9674177</ArticleId><ArticleId IdType="pubmed">36399443</ArticleId></ArticleIdList></Reference><Reference><Citation>Dadonaite B., Crawford K.H.D., Radford C.E., Farrell A.G., Yu T.C., Hannon W.W., Zhou P., Andrabi R., Burton D.R., Liu L., et al. A Pseudovirus System Enables Deep Mutational Scanning of the Full SARS-CoV-2 Spike. Cell. 2023;186:1263–1278.e20. doi: 10.1016/j.cell.2023.02.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2023.02.001</ArticleId><ArticleId IdType="pmc">PMC9922669</ArticleId><ArticleId IdType="pubmed">36868218</ArticleId></ArticleIdList></Reference><Reference><Citation>Starr T.N., Greaney A.J., Hannon W.W., Loes A.N., Hauser K., Dillen J.R., Ferri E., Farrell A.G., Dadonaite B., McCallum M., et al. Shifting Mutational Constraints in the SARS-CoV-2 Receptor-Binding Domain during Viral Evolution. Science. 2022;377:420–424. doi: 10.1126/science.abo7896.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abo7896</ArticleId><ArticleId IdType="pmc">PMC9273037</ArticleId><ArticleId IdType="pubmed">35762884</ArticleId></ArticleIdList></Reference><Reference><Citation>Moulana A., Dupic T., Phillips A.M., Chang J., Nieves S., Roffler A.A., Greaney A.J., Starr T.N., Bloom J.D., Desai M.M. Compensatory Epistasis Maintains ACE2 Affinity in SARS-CoV-2 Omicron BA.1. Nat. Commun. 2022;13:7011. doi: 10.1038/s41467-022-34506-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-34506-z</ArticleId><ArticleId IdType="pmc">PMC9668218</ArticleId><ArticleId IdType="pubmed">36384919</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor A.L., Starr T.N. Deep Mutational Scans of XBB.1.5 and BQ.1.1 Reveal Ongoing Epistatic Drift during SARS-CoV-2 Evolution. PLoS Pathog. 2023;19:e1011901. doi: 10.1371/journal.ppat.1011901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1011901</ArticleId><ArticleId IdType="pmc">PMC10783747</ArticleId><ArticleId IdType="pubmed">38157379</ArticleId></ArticleIdList></Reference><Reference><Citation>Jian F., Wang J., Yisimayi A., Song W., Xu Y., Chen X., Niu X., Yang S., Yu Y., Wang P., et al. Evolving Antibody Response to SARS-CoV-2 Antigenic Shift from XBB to JN.1. bioRxiv. 2024 doi: 10.1101/2024.04.19.590276.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2024.04.19.590276</ArticleId></ArticleIdList></Reference><Reference><Citation>Planas D., Staropoli I., Michel V., Lemoine F., Donati F., Prot M., Porrot F., Guivel-Benhassine F., Jeyarajah B., Brisebarre A., et al. Distinct Evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineages Combining Increased Fitness and Antibody Evasion. Nat. Commun. 2024;15:2254. doi: 10.1038/s41467-024-46490-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-024-46490-7</ArticleId><ArticleId IdType="pmc">PMC10938001</ArticleId><ArticleId IdType="pubmed">38480689</ArticleId></ArticleIdList></Reference><Reference><Citation>Casalino L., Gaieb Z., Goldsmith J.A., Hjorth C.K., Dommer A.C., Harbison A.M., Fogarty C.A., Barros E.P., Taylor B.C., McLellan J.S., et al. Beyond shielding: The roles of glycans in the SARS-CoV-2 spike potein. ACS Cent. Sci. 2020;6:1722–1734. doi: 10.1021/acscentsci.0c01056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acscentsci.0c01056</ArticleId><ArticleId IdType="pmc">PMC7523240</ArticleId><ArticleId IdType="pubmed">33140034</ArticleId></ArticleIdList></Reference><Reference><Citation>Sztain T., Ahn S.H., Bogetti A.T., Casalino L., Goldsmith J.A., Seitz E., McCool R.S., Kearns F.L., Acosta-Reyes F., Maji S., et al. A glycan gate controls the opening of the SARS-CoV-2 spike protein. Nat. Chem. 2021;13:963–968. doi: 10.1038/s41557-021-00758-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41557-021-00758-3</ArticleId><ArticleId IdType="pmc">PMC8488004</ArticleId><ArticleId IdType="pubmed">34413500</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang Y.T., Acharya A., Lynch D.L., Pavlova A., Gumbart J.C. SARS-CoV-2 Spike Opening Dynamics and Energetics Reveal the Individual Roles of Glycans and Their Collective Impact. Commun. Biol. 2022;5:1170. doi: 10.1038/s42003-022-04138-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-022-04138-6</ArticleId><ArticleId IdType="pmc">PMC9631587</ArticleId><ArticleId IdType="pubmed">36329138</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmerman M.I., Porter J.R., Ward M.D., Singh S., Vithani N., Meller A., Mallimadugula U.L., Kuhn C.E., Borowsky J.H., Wiewiora R.P., et al. SARS-CoV-2 simulations go exascale to predict dramatic spike opening and cryptic pockets across the proteome. Nat. Chem. 2021;13:651–659. doi: 10.1038/s41557-021-00707-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41557-021-00707-0</ArticleId><ArticleId IdType="pmc">PMC8249329</ArticleId><ArticleId IdType="pubmed">34031561</ArticleId></ArticleIdList></Reference><Reference><Citation>Dokainish H.M., Re S., Mori T., Kobayashi C., Jung J., Sugita Y. The inherent flexibility of receptor binding domains in SARS-CoV-2 spike protein. Elife. 2022;11:e75720. doi: 10.7554/eLife.75720.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.75720</ArticleId><ArticleId IdType="pmc">PMC8963885</ArticleId><ArticleId IdType="pubmed">35323112</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh J., Vashishtha S., Kundu B. Spike Protein Mutation-Induced Changes in the Kinetic and Thermodynamic Behavior of Its Receptor Binding Domains Explain Their Higher Propensity to Attain Open States in SARS-CoV-2 Variants of Concern. ACS Cent. Sci. 2023;9:1894–1904. doi: 10.1021/acscentsci.3c00810.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acscentsci.3c00810</ArticleId><ArticleId IdType="pmc">PMC10604015</ArticleId><ArticleId IdType="pubmed">37901170</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y., Li M., Wang Q. Allosteric pathways of SARS and SARS-CoV-2 spike protein identified by neural relational inference. Proteins. 2024;92:865–873. doi: 10.1002/prot.26678.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prot.26678</ArticleId><ArticleId IdType="pubmed">38459426</ArticleId></ArticleIdList></Reference><Reference><Citation>Verkhivker G.M., Di Paola L. Integrated Biophysical Modeling of the SARS-CoV-2 Spike Protein Binding and Allosteric Interactions with Antibodies. J. Phys. Chem. B. 2021;125:4596–4619. doi: 10.1021/acs.jpcb.1c00395.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jpcb.1c00395</ArticleId><ArticleId IdType="pubmed">33929853</ArticleId></ArticleIdList></Reference><Reference><Citation>Verkhivker G.M., Agajanian S., Oztas D.Y., Gupta G. Comparative Perturbation-Based Modeling of the SARS-CoV-2 Spike Protein Binding with Host Receptor and Neutralizing Antibodies: Structurally Adaptable Allosteric Communication Hotspots Define Spike Sites Targeted by Global Circulating Mutations. Biochemistry. 2021;60:1459–1484. doi: 10.1021/acs.biochem.1c00139.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.biochem.1c00139</ArticleId><ArticleId IdType="pubmed">33900725</ArticleId></ArticleIdList></Reference><Reference><Citation>Verkhivker G.M., Agajanian S., Oztas D.Y., Gupta G. Dynamic Profiling of Binding and Allosteric Propensities of the SARS-CoV-2 Spike Protein with Different Classes of Antibodies: Mutational and Perturbation-Based Scanning Reveals the Allosteric Duality of Functionally Adaptable Hotspots. J. Chem. Theory Comput. 2021;17:4578–4598. doi: 10.1021/acs.jctc.1c00372.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jctc.1c00372</ArticleId><ArticleId IdType="pubmed">34138559</ArticleId></ArticleIdList></Reference><Reference><Citation>Verkhivker G., Alshahrani M., Gupta G. Balancing Functional Tradeoffs between Protein Stability and ACE2 Binding in the SARS-CoV-2 Omicron BA.2, BA.2.75 and XBB Lineages: Dynamics-Based Network Models Reveal Epistatic Effects Modulating Compensatory Dynamic and Energetic Changes. Viruses. 2023;15:1143. doi: 10.3390/v15051143.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15051143</ArticleId><ArticleId IdType="pmc">PMC10221141</ArticleId><ArticleId IdType="pubmed">37243229</ArticleId></ArticleIdList></Reference><Reference><Citation>Verkhivker G., Alshahrani M., Gupta G., Xiao S., Tao P. Probing Conformational Landscapes of Binding and Allostery in the SARS-CoV-2 Omicron Variant Complexes Using Microsecond Atomistic Simulations and Perturbation-Based Profiling Approaches: Hidden Role of Omicron Mutations as Modulators of Allosteric Signaling and Epistatic Relationships. Phys. Chem. Chem. Phys. 2023;25:21245–21266. doi: 10.1039/d3cp02042h.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/d3cp02042h</ArticleId><ArticleId IdType="pmc">PMC10536792</ArticleId><ArticleId IdType="pubmed">37548589</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao S., Alshahrani M., Gupta G., Tao P., Verkhivker G. Markov State Models and Perturbation-Based Approaches Reveal Distinct Dynamic Signatures and Hidden Allosteric Pockets in the Emerging SARS-CoV-2 Spike Omicron Variant Complexes with the Host Receptor: The Interplay of Dynamics and Convergent Evolution Modulates Allostery and Functional Mechanisms. J. Chem. Inf. Model. 2023;63:5272–5296. doi: 10.1021/acs.jcim.3c00778.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jcim.3c00778</ArticleId><ArticleId IdType="pmc">PMC11162552</ArticleId><ArticleId IdType="pubmed">37549201</ArticleId></ArticleIdList></Reference><Reference><Citation>Raisinghani N., Alshahrani M., Gupta G., Xiao S., Tao P., Verkhivker G. AlphaFold2-Enabled Atomistic Modeling of Structure, Conformational Ensembles, and Binding Energetics of the SARS-CoV-2 Omicron BA.2.86 Spike Protein with ACE2 Host Receptor and Antibodies: Compensatory Functional Effects of Binding Hotspots in Modulating Mechanisms of Receptor Binding and Immune Escape. J. Chem. Inf. Model. 2024;64:1657–1681. doi: 10.1021/acs.jcim.3c01857.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jcim.3c01857</ArticleId><ArticleId IdType="pubmed">38373700</ArticleId></ArticleIdList></Reference><Reference><Citation>Raisinghani N., Alshahrani M., Gupta G., Xiao S., Tao P., Verkhivker G. AlphaFold2 Predictions of Conformational Ensembles and Atomistic Simulations of the SARS-CoV-2 Spike XBB Lineages Reveal Epistatic Couplings between Convergent Mutational Hotspots That Control ACE2 Affinity. J. Phys. Chem. B. 2024;128:4696–4715. doi: 10.1021/acs.jpcb.4c01341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jpcb.4c01341</ArticleId><ArticleId IdType="pubmed">38696745</ArticleId></ArticleIdList></Reference><Reference><Citation>Raisinghani N., Alshahrani M., Gupta G., Verkhivker G. Ensemble-Based Mutational Profiling and Network Analysis of the SARS-CoV-2 Spike Omicron XBB Lineages for Interactions with the ACE2 Receptor and Antibodies: Cooperation of Binding Hotspots in Mediating Epistatic Couplings Underlies Binding Mechanism and Immune Escape. Int. J. Mol. Sci. 2024;25:4281. doi: 10.3390/ijms25084281.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms25084281</ArticleId><ArticleId IdType="pmc">PMC11049863</ArticleId><ArticleId IdType="pubmed">38673865</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z., Zeng X., Zhao Y., Chen R. AlphaFold2 and Its Applications in the Fields of Biology and Medicine. Signal Transduct. Target Ther. 2023;8:115. doi: 10.1038/s41392-023-01381-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-023-01381-z</ArticleId><ArticleId IdType="pmc">PMC10011802</ArticleId><ArticleId IdType="pubmed">36918529</ArticleId></ArticleIdList></Reference><Reference><Citation>Buel G.R., Walters K.J. Can AlphaFold2 Predict the Impact of Missense Mutations on Structure? Nat. Struct. Mol. Biol. 2022;29:1–2. doi: 10.1038/s41594-021-00714-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-021-00714-2</ArticleId><ArticleId IdType="pmc">PMC11218004</ArticleId><ArticleId IdType="pubmed">35046575</ArticleId></ArticleIdList></Reference><Reference><Citation>Pak M.A., Markhieva K.A., Novikova M.S., Petrov D.S., Vorobyev I.S., Maksimova E.S., Kondrashov F.A., Ivankov D.N. Using AlphaFold to Predict the Impact of Single Mutations on Protein Stability and Function. PLoS ONE. 2023;18:e0282689. doi: 10.1371/journal.pone.0282689.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0282689</ArticleId><ArticleId IdType="pmc">PMC10019719</ArticleId><ArticleId IdType="pubmed">36928239</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein R.A., Mchaourab H.S. Rosetta Energy Analysis of AlphaFold2 Models: Point Mutations and Conformational Ensembles. bioRxiv. 2024 doi: 10.1101/2023.09.05.556364.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.09.05.556364</ArticleId></ArticleIdList></Reference><Reference><Citation>McBride J.M., Polev K., Abdirasulov A., Reinharz V., Grzybowski B.A., Tlusty T. AlphaFold2 Can Predict Single-Mutation Effects. Phys. Rev. Lett. 2023;131:218401. doi: 10.1103/PhysRevLett.131.218401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1103/PhysRevLett.131.218401</ArticleId><ArticleId IdType="pubmed">38072605</ArticleId></ArticleIdList></Reference><Reference><Citation>McBride J.M., Tlusty T. AI-Predicted Protein Deformation Encodes Energy Landscape Perturbation. Phys. Rev. Lett. 2024;133:098410. doi: 10.1103/PhysRevLett.133.098401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1103/PhysRevLett.133.098401</ArticleId><ArticleId IdType="pubmed">39270162</ArticleId></ArticleIdList></Reference><Reference><Citation>Jumper J., Evans R., Pritzel A., Green T., Figurnov M., Ronneberger O., Tunyasuvunakool K., Bates R., Žídek A., Potapenko A., et al. Highly Accurate Protein Structure Prediction with AlphaFold. Nature. 2021;596:583–589. doi: 10.1038/s41586-021-03819-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03819-2</ArticleId><ArticleId IdType="pmc">PMC8371605</ArticleId><ArticleId IdType="pubmed">34265844</ArticleId></ArticleIdList></Reference><Reference><Citation>Tunyasuvunakool K., Adler J., Wu Z., Green T., Zielinski M., Žídek A., Bridgland A., Cowie A., Meyer C., Laydon A., et al. Highly Accurate Protein Structure Prediction for the Human Proteome. Nature. 2021;596:590–596. doi: 10.1038/s41586-021-03828-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03828-1</ArticleId><ArticleId IdType="pmc">PMC8387240</ArticleId><ArticleId IdType="pubmed">34293799</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Alamo D., Sala D., Mchaourab H.S., Meiler J. Sampling alternative conformational states of transporters and receptors with AlphaFold2. Elife. 2022;11:e75751. doi: 10.7554/eLife.75751.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.75751</ArticleId><ArticleId IdType="pmc">PMC9023059</ArticleId><ArticleId IdType="pubmed">35238773</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein R.A., Mchaourab H.S. SPEACH_AF: Sampling Protein Ensembles and Conformational Heterogeneity with Alphafold2. PLoS Comput. Biol. 2022;18:e1010483. doi: 10.1371/journal.pcbi.1010483.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1010483</ArticleId><ArticleId IdType="pmc">PMC9436118</ArticleId><ArticleId IdType="pubmed">35994486</ArticleId></ArticleIdList></Reference><Reference><Citation>Wayment-Steele H.K., Ovchinnikov S., Colwell L., Kern D. Predicting multiple conformations via sequence clustering and AlphaFold2. Nature. 2023;625:832–839. doi: 10.1038/s41586-023-06832-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-06832-9</ArticleId><ArticleId IdType="pmc">PMC10808063</ArticleId><ArticleId IdType="pubmed">37956700</ArticleId></ArticleIdList></Reference><Reference><Citation>Park Y.-J., De Marco A., Starr T.N., Liu Z., Pinto D., Walls A.C., Zatta F., Zepeda S.K., Bowen J.E., Sprouse K.R., et al. Antibody-Mediated Broad Sarbecovirus Neutralization through ACE2 Molecular Mimicry. Science. 2022;375:449–454. doi: 10.1126/science.abm8143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm8143</ArticleId><ArticleId IdType="pmc">PMC9400459</ArticleId><ArticleId IdType="pubmed">34990214</ArticleId></ArticleIdList></Reference><Reference><Citation>Cameroni E., Bowen J.E., Rosen L.E., Saliba C., Zepeda S.K., Culap K., Pinto D., VanBlargan L.A., De Marco A., di Iulio J., et al. Broadly Neutralizing Antibodies Overcome SARS-CoV-2 Omicron Antigenic Shift. Nature. 2022;602:664–670. doi: 10.1038/s41586-021-04386-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04386-2</ArticleId><ArticleId IdType="pmc">PMC9531318</ArticleId><ArticleId IdType="pubmed">35016195</ArticleId></ArticleIdList></Reference><Reference><Citation>Nutalai R., Zhou D., Tuekprakhon A., Ginn H.M., Supasa P., Liu C., Huo J., Mentzer A.J., Duyvesteyn H.M.E., Dijokaite-Guraliuc A., et al. Potent Cross-Reactive Antibodies Following Omicron Breakthrough in Vaccinees. Cell. 2022;185:2116–2131.e18. doi: 10.1016/j.cell.2022.05.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.05.014</ArticleId><ArticleId IdType="pmc">PMC9120130</ArticleId><ArticleId IdType="pubmed">35662412</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Y., Jian F., Zhang Z., Yisimayi A., Hao X., Bao L., Yuan F., Yu Y., Du S., Wang J., et al. Rational Identification of Potent and Broad Sarbecovirus-Neutralizing Antibody Cocktails from SARS Convalescents. Cell Rep. 2022;41:111845. doi: 10.1016/j.celrep.2022.111845.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2022.111845</ArticleId><ArticleId IdType="pmc">PMC9712074</ArticleId><ArticleId IdType="pubmed">36493787</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Y., Yisimayi A., Bai Y., Huang W., Li X., Zhang Z., Yuan T., An R., Wang J., Xiao T., et al. Humoral Immune Response to Circulating SARS-CoV-2 Variants Elicited by Inactivated and RBD-Subunit Vaccines. Cell Res. 2021;31:732–741. doi: 10.1038/s41422-021-00514-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-021-00514-9</ArticleId><ArticleId IdType="pmc">PMC8138844</ArticleId><ArticleId IdType="pubmed">34021265</ArticleId></ArticleIdList></Reference><Reference><Citation>Muecksch F., Wang Z., Cho A., Gaebler C., Ben Tanfous T., DaSilva J., Bednarski E., Ramos V., Zong S., Johnson B., et al. Increased Memory B Cell Potency and Breadth after a SARS-CoV-2 mRNA Boost. Nature. 2022;607:128–134. doi: 10.1038/s41586-022-04778-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04778-y</ArticleId><ArticleId IdType="pmc">PMC9259484</ArticleId><ArticleId IdType="pubmed">35447027</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirdita M., Schütze K., Moriwaki Y., Heo L., Ovchinnikov S., Steinegger M. ColabFold: Making Protein Folding Accessible to All. Nat. Methods. 2022;19:679–682. doi: 10.1038/s41592-022-01488-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41592-022-01488-1</ArticleId><ArticleId IdType="pmc">PMC9184281</ArticleId><ArticleId IdType="pubmed">35637307</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y. TM-Align: A Protein Structure Alignment Algorithm Based on the TM-Score. Nucleic Acids Res. 2005;33:2302–2309. doi: 10.1093/nar/gki524.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gki524</ArticleId><ArticleId IdType="pmc">PMC1084323</ArticleId><ArticleId IdType="pubmed">15849316</ArticleId></ArticleIdList></Reference><Reference><Citation>Rose P.W., Prlic A., Altunkaya A., Bi C., Bradley A.R., Christie C.H., Costanzo L.D., Duarte J.M., Dutta S., Feng Z., et al. The RCSB protein data bank: Integrative view of protein, gene and 3D structural information. Nucleic Acids Res. 2017;45:D271–D281. doi: 10.1093/nar/gkw1000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw1000</ArticleId><ArticleId IdType="pmc">PMC5210513</ArticleId><ArticleId IdType="pubmed">27794042</ArticleId></ArticleIdList></Reference><Reference><Citation>Hekkelman M.L., Te Beek T.A., Pettifer S.R., Thorne D., Attwood T.K., Vriend G. WIWS: A protein structure bioinformatics web service collection. Nucleic Acids Res. 2010;38:W719–W723. doi: 10.1093/nar/gkq453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkq453</ArticleId><ArticleId IdType="pmc">PMC2896166</ArticleId><ArticleId IdType="pubmed">20501602</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Fuentes N., Zhai J., Fiser A. ArchPRED: A template based loop structure prediction server. Nucleic Acids Res. 2006;34:W173–W176. doi: 10.1093/nar/gkl113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkl113</ArticleId><ArticleId IdType="pmc">PMC1538831</ArticleId><ArticleId IdType="pubmed">16844985</ArticleId></ArticleIdList></Reference><Reference><Citation>Krivov G.G., Shapovalov M.V., Dunbrack R.L., Jr. Improved prediction of protein side-chain conformations with SCWRL4. Proteins. 2009;77:778–795. doi: 10.1002/prot.22488.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prot.22488</ArticleId><ArticleId IdType="pmc">PMC2885146</ArticleId><ArticleId IdType="pubmed">19603484</ArticleId></ArticleIdList></Reference><Reference><Citation>Søndergaard C.R., Olsson M.H., Rostkowski M., Jensen J.H. Improved treatment of ligands and coupling effects in empirical calculation and rationalization of pKa values. J. Chem. Theory Comput. 2011;7:2284–2295. doi: 10.1021/ct200133y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ct200133y</ArticleId><ArticleId IdType="pubmed">26606496</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsson M.H., Søndergaard C.R., Rostkowski M., Jensen J.H. PROPKA3: Consistent treatment of internal and surface residues in empirical pKa predictions. J. Chem. Theory Comput. 2011;7:525–537. doi: 10.1021/ct100578z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ct100578z</ArticleId><ArticleId IdType="pubmed">26596171</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharya D., Cheng J. 3Drefine: Consistent Protein Structure Refinement by Optimizing Hydrogen Bonding Network and Atomic-Level Energy Minimization. Proteins. 2013;81:119–131. doi: 10.1002/prot.24167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prot.24167</ArticleId><ArticleId IdType="pmc">PMC3634918</ArticleId><ArticleId IdType="pubmed">22927229</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharya D., Nowotny J., Cao R., Cheng J. 3Drefine: An Interactive Web Server for Efficient Protein Structure Refinement. Nucleic Acids Res. 2016;44:W406–W409. doi: 10.1093/nar/gkw336.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw336</ArticleId><ArticleId IdType="pmc">PMC4987902</ArticleId><ArticleId IdType="pubmed">27131371</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips J.C., Hardy D.J., Maia J.D.C., Stone J.E., Ribeiro J.V., Bernardi R.C., Buch R., Fiorin G., Hénin J., Jiang W., et al. Scalable Molecular Dynamics on CPU and GPU Architectures with NAMD. J. Chem. Phys. 2020;153:044130. doi: 10.1063/5.0014475.</Citation><ArticleIdList><ArticleId IdType="doi">10.1063/5.0014475</ArticleId><ArticleId IdType="pmc">PMC7395834</ArticleId><ArticleId IdType="pubmed">32752662</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J., Rauscher S., Nawrocki G., Ran T., Feig M., de Groot B.L., Grubmüller H., MacKerell A.D., Jr. CHARMM36m: An improved force field for folded and intrinsically disordered proteins. Nat. Methods. 2017;14:71–73. doi: 10.1038/nmeth.4067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.4067</ArticleId><ArticleId IdType="pmc">PMC5199616</ArticleId><ArticleId IdType="pubmed">27819658</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandes H.S., Sousa S.F., Cerqueira N.M.F.S.A. VMD Store-A VMD Plugin to Browse, Discover, and Install VMD Extensions. J. Chem. Inf. Model. 2019;59:4519–4523. doi: 10.1021/acs.jcim.9b00739.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jcim.9b00739</ArticleId><ArticleId IdType="pubmed">31682440</ArticleId></ArticleIdList></Reference><Reference><Citation>Jo S., Kim T., Iyer V.G., Im W. CHARMM-GUI: A Web-based Graphical User Interface for CHARMM. J. Comput Chem. 2008;29:1859–1865. doi: 10.1002/jcc.20945.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcc.20945</ArticleId><ArticleId IdType="pubmed">18351591</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J., Cheng X., Swails J.M., Yeom M.S., Eastman P.K., Lemkul J.A., Wei S., Buckner J., Jeong J.C., Qi Y., et al. CHARMM-GUI Input Generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM Simulations Using the CHARMM36 Additive Force Field. J Chem. Theory Comput. 2016;12:405–413. doi: 10.1021/acs.jctc.5b00935.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jctc.5b00935</ArticleId><ArticleId IdType="pmc">PMC4712441</ArticleId><ArticleId IdType="pubmed">26631602</ArticleId></ArticleIdList></Reference><Reference><Citation>Jorgensen W.L., Chandrasekhar J., Madura J.D., Impey R.W., Klein M.L. Comparison of Simple Potential Functions for Simulating Liquid Water. J. Chem. Phys. 1983;79:926–935. doi: 10.1063/1.445869.</Citation><ArticleIdList><ArticleId IdType="doi">10.1063/1.445869</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross G.A., Rustenburg A.S., Grinaway P.B., Fass J., Chodera J.D. Biomolecular Simulations under Realistic Macroscopic Salt Conditions. J. Phys. Chem. B. 2018;122:5466–5486. doi: 10.1021/acs.jpcb.7b11734.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jpcb.7b11734</ArticleId><ArticleId IdType="pmc">PMC6078207</ArticleId><ArticleId IdType="pubmed">29649876</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Pierro M., Elber R., Leimkuhler B. A Stochastic Algorithm for the Isobaric-Isothermal Ensemble with Ewald Summations for All Long Range Forces. J. Chem. Theory Comput. 2015;11:5624–5637. doi: 10.1021/acs.jctc.5b00648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jctc.5b00648</ArticleId><ArticleId IdType="pmc">PMC4890727</ArticleId><ArticleId IdType="pubmed">26616351</ArticleId></ArticleIdList></Reference><Reference><Citation>Martyna G.J., Tobias D.J., Klein M.L. Constant pressure molecular dynamics algorithms. J. Chem. Phys. 1994;101:4177–4189. doi: 10.1063/1.467468.</Citation><ArticleIdList><ArticleId IdType="doi">10.1063/1.467468</ArticleId></ArticleIdList></Reference><Reference><Citation>Feller S.E., Zhang Y., Pastor R.W., Brooks B.R. Constant pressure molecular dynamics simulation: The Langevin piston method. J. Chem. Phys. 1995;103:4613–4621. doi: 10.1063/1.470648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1063/1.470648</ArticleId></ArticleIdList></Reference><Reference><Citation>Davidchack R.L., Handel R., Tretyakov M.V. Langevin thermostat for rigid body dynamics. J. Chem. Phys. 2009;130:234101. doi: 10.1063/1.3149788.</Citation><ArticleIdList><ArticleId IdType="doi">10.1063/1.3149788</ArticleId><ArticleId IdType="pubmed">19548705</ArticleId></ArticleIdList></Reference><Reference><Citation>Sacquin-Mora S., Lavery R. Investigating the local flexibility of functional residues in hemoproteins. Biophys. J. 2006;90:2706–2717. doi: 10.1529/biophysj.105.074997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1529/biophysj.105.074997</ArticleId><ArticleId IdType="pmc">PMC1414562</ArticleId><ArticleId IdType="pubmed">16428284</ArticleId></ArticleIdList></Reference><Reference><Citation>Sacquin-Mora S., Laforet E., Lavery R. Locating the active sites of enzymes using mechanical properties. Proteins. 2007;67:350–359. doi: 10.1002/prot.21353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prot.21353</ArticleId><ArticleId IdType="pubmed">17311346</ArticleId></ArticleIdList></Reference><Reference><Citation>Sacquin-Mora S. Motions and Mechanics: Investigating Conformational Transitions in Multi-Domain Proteins with Coarse-Grain Simulations. Mol. Simul. 2014;40:229–236. doi: 10.1080/08927022.2013.843176.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08927022.2013.843176</ArticleId></ArticleIdList></Reference><Reference><Citation>Dehouck Y., Kwasigroch J.M., Rooman M., Gilis D. BeAtMuSiC: Prediction of changes in protein-protein binding affinity on mutations. Nucleic Acids Res. 2013;41:W333–W339. doi: 10.1093/nar/gkt450.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkt450</ArticleId><ArticleId IdType="pmc">PMC3692068</ArticleId><ArticleId IdType="pubmed">23723246</ArticleId></ArticleIdList></Reference><Reference><Citation>Dehouck Y., Gilis D., Rooman M. A new generation of statistical potentials for proteins. Biophys. J. 2006;90:4010–4017. doi: 10.1529/biophysj.105.079434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1529/biophysj.105.079434</ArticleId><ArticleId IdType="pmc">PMC1459517</ArticleId><ArticleId IdType="pubmed">16533849</ArticleId></ArticleIdList></Reference><Reference><Citation>Dehouck Y., Grosfils A., Folch B., Gilis D., Bogaerts P., Rooman M. Fast and accurate predictions of protein stability changes upon mutations using statistical potentials and neural networks:PoPMuSiC-2.0. Bioinformatics. 2009;25:2537–2543. doi: 10.1093/bioinformatics/btp445.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btp445</ArticleId><ArticleId IdType="pubmed">19654118</ArticleId></ArticleIdList></Reference><Reference><Citation>Srinivasan J., Cheatham T.E., Cieplak P., Kollman P.A., Case D.A. Continuum Solvent Studies of the Stability of DNA, RNA, and Phosphoramidate−DNA Helices. J. Am. Chem. Soc. 1998;120:9401–9409. doi: 10.1021/ja981844+.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ja981844+</ArticleId></ArticleIdList></Reference><Reference><Citation>Kollman P.A., Massova I., Reyes C., Kuhn B., Huo S., Chong L., Lee M., Lee T., Duan Y., Wang W., et al. Calculating Structures and Free Energies of Complex Molecules:  Combining Molecular Mechanics and Continuum Models. Acc. Chem. Res. 2000;33:889–897. doi: 10.1021/ar000033j.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ar000033j</ArticleId><ArticleId IdType="pubmed">11123888</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou T., Wang J., Li Y., Wang W. Assessing the Performance of the MM/PBSA and MM/GBSA Methods. 1. The Accuracy of Binding Free Energy Calculations Based on Molecular Dynamics Simulations. J. Chem. Inf. Model. 2011;51:69–82. doi: 10.1021/ci100275a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ci100275a</ArticleId><ArticleId IdType="pmc">PMC3029230</ArticleId><ArticleId IdType="pubmed">21117705</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng G., Wang E., Wang Z., Liu H., Zhu F., Li D., Hou T. HawkDock: A Web Server to Predict and Analyze the Protein–Protein Complex Based on Computational Docking and MM/GBSA. Nucleic Acids Res. 2019;47:W322–W330. doi: 10.1093/nar/gkz397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkz397</ArticleId><ArticleId IdType="pmc">PMC6602443</ArticleId><ArticleId IdType="pubmed">31106357</ArticleId></ArticleIdList></Reference><Reference><Citation>Mongan J., Simmerling C., McCammon J.A., Case D.A., Onufriev A. Generalized Born Model with a Simple, Robust Molecular Volume Correction. J. Chem. Theory Comput. 2007;3:156–169. doi: 10.1021/ct600085e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ct600085e</ArticleId><ArticleId IdType="pmc">PMC2975579</ArticleId><ArticleId IdType="pubmed">21072141</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams A.H., Zhan C.-G. Generalized Methodology for the Quick Prediction of Variant SARS-CoV-2 Spike Protein Binding Affinities with Human Angiotensin-Converting Enzyme II. J. Phys. Chem. B. 2022;126:2353–2360. doi: 10.1021/acs.jpcb.1c10718.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jpcb.1c10718</ArticleId><ArticleId IdType="pmc">PMC8982491</ArticleId><ArticleId IdType="pubmed">35315274</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun H., Duan L., Chen F., Liu H., Wang Z., Pan P., Zhu F., Zhang J.Z.H., Hou T. Assessing the Performance of MM/PBSA and MM/GBSA Methods. 7. Entropy Effects on the Performance of End-Point Binding Free Energy Calculation Approaches. Phys. Chem. Chem. Phys. 2018;20:14450–14460. doi: 10.1039/C7CP07623A.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C7CP07623A</ArticleId><ArticleId IdType="pubmed">29785435</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller B.R., III, McGee T.D., Jr., Swails J.M., Homeyer N., Gohlke H., Roitberg A.E. MMPBSA.Py: An Efficient Program for End-State Free Energy Calculations. J Chem Theory Comput. 2012;8:3314–3321. doi: 10.1021/ct300418h.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ct300418h</ArticleId><ArticleId IdType="pubmed">26605738</ArticleId></ArticleIdList></Reference><Reference><Citation>Valdés-Tresanco M.S., Valdés-Tresanco M.E., Valiente P.A., Moreno E. gmx_MMPBSA: A New Tool to Perform End-State Free Energy Calculations with GROMACS. J. Chem. Theory Comput. 2021;17:6281–6291. doi: 10.1021/acs.jctc.1c00645.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jctc.1c00645</ArticleId><ArticleId IdType="pubmed">34586825</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Lu L., Jiang S. SARS-CoV-2 Omicron Subvariant BA.2.86: Limited Potential for Global Spread. Signal Transduct. Target Ther. 2023;8:439. doi: 10.1038/s41392-023-01712-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-023-01712-0</ArticleId><ArticleId IdType="pmc">PMC10689828</ArticleId><ArticleId IdType="pubmed">38036521</ArticleId></ArticleIdList></Reference><Reference><Citation>Jian F., Feng L., Yang S., Yu Y., Wang L., Song W., Yisimayi A., Chen X., Xu Y., Wang P., et al. Convergent Evolution of SARS-CoV-2 XBB Lineages on Receptor-Binding Domain 455-456 Synergistically Enhances Antibody Evasion and ACE2 Binding. PLoS Pathog. 2023;19:e1011868. doi: 10.1371/journal.ppat.1011868.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1011868</ArticleId><ArticleId IdType="pmc">PMC10766189</ArticleId><ArticleId IdType="pubmed">38117863</ArticleId></ArticleIdList></Reference><Reference><Citation>Harvey W.T., Carabelli A.M., Jackson B., Gupta R.K., Thomson E.C., Harrison E.M., Ludden C., Reeve R., Rambaut A., Peacock S.J., et al. SARS-CoV-2 Variants, Spike Mutations and Immune Escape. Nat. Rev. Microbiol. 2021;19:409–424. doi: 10.1038/s41579-021-00573-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-021-00573-0</ArticleId><ArticleId IdType="pmc">PMC8167834</ArticleId><ArticleId IdType="pubmed">34075212</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao Y., Zheng B., Ding X., Zheng P. Probing Nanomechanical Interactions of SARS-CoV-2 Variants Omicron and XBB with Common Surfaces. Chem. Commun. 2023;59:11268–11271. doi: 10.1039/D3CC02721J.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/D3CC02721J</ArticleId><ArticleId IdType="pubmed">37664897</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian F., Tong B., Sun L., Shi S., Zheng B., Wang Z., Dong X., Zheng P. N501Y Mutation of Spike Protein in SARS-CoV-2 Strengthens Its Binding to Receptor ACE2. Elife. 2021;10:e69091. doi: 10.7554/eLife.69091.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.69091</ArticleId><ArticleId IdType="pmc">PMC8455130</ArticleId><ArticleId IdType="pubmed">34414884</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Z., Xie Y., Bai B., Luo C., Zhou J., Li W., Meng Y., Li L., Li D., Li X., et al. Structural Basis for Receptor Binding and Broader Interspecies Receptor Recognition of Currently Circulating Omicron Sub-Variants. Nat. Commun. 2023;14:4405. doi: 10.1038/s41467-023-39942-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-39942-z</ArticleId><ArticleId IdType="pmc">PMC10362042</ArticleId><ArticleId IdType="pubmed">37479708</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L., Shi K., Gu Y., Xu Z., Shu C., Li D., Sun J., Cong M., Li X., Zhao X., et al. Spike Structures, Receptor Binding, and Immune Escape of Recently Circulating SARS-CoV-2 Omicron BA.2.86, JN.1, EG.5, EG.5.1, and HV.1 Sub-Variants. Structure. 2024;32:1055–1067.e6. doi: 10.1016/j.str.2024.06.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.str.2024.06.012</ArticleId><ArticleId IdType="pubmed">39013463</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayarri-Olmos R., Rosbjerg A., Johnsen L.B., Helgstrand C., Bak-Thomsen T., Garred P., Skjoedt M.-O. The SARS-CoV-2 Y453F Mink Variant Displays a Pronounced Increase in ACE-2 Affinity but Does Not Challenge Antibody Neutralization. J. Biol. Chem. 2021;296:100536. doi: 10.1016/j.jbc.2021.100536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2021.100536</ArticleId><ArticleId IdType="pmc">PMC7948531</ArticleId><ArticleId IdType="pubmed">33716040</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren W., Lan J., Ju X., Gong M., Long Q., Zhu Z., Yu Y., Wu J., Zhong J., Zhang R., et al. Mutation Y453F in the Spike Protein of SARS-CoV-2 Enhances Interaction with the Mink ACE2 Receptor for Host Adaption. PLoS Pathog. 2021;17:e1010053. doi: 10.1371/journal.ppat.1010053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1010053</ArticleId><ArticleId IdType="pmc">PMC8601601</ArticleId><ArticleId IdType="pubmed">34748603</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan K.K., Tan T.J.C., Narayanan K.K., Procko E. An Engineered Decoy Receptor for SARS-CoV-2 Broadly Binds Protein S Sequence Variants. Sci. Adv. 2021;7:eabf1738. doi: 10.1126/sciadv.abf1738.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abf1738</ArticleId><ArticleId IdType="pmc">PMC7888922</ArticleId><ArticleId IdType="pubmed">33597251</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Y., Yisimayi A., Jian F., Song W., Xiao T., Wang L., Du S., Wang J., Li Q., Chen X., et al. BA.2.12.1, BA.4 and BA.5 Escape Antibodies Elicited by Omicron Infection. Nature. 2022;608:593–602. doi: 10.1038/s41586-022-04980-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04980-y</ArticleId><ArticleId IdType="pmc">PMC9385493</ArticleId><ArticleId IdType="pubmed">35714668</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu L., Wang Y., Liu Y., Xing X., Li C., Wang X., Shi J., Ma W., Li J., Chen Y., et al. Potent and Broadly Neutralizing Antibodies against Sarbecoviruses Elicited by Single Ancestral SARS-CoV-2 Infection. bioRxiv. 2024 doi: 10.1101/2024.06.06.597720.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2024.06.06.597720</ArticleId></ArticleIdList></Reference><Reference><Citation>Ose N.J., Campitelli P., Modi T., Kazan I.C., Kumar S., Ozkan S.B. Some Mechanistic Underpinnings of Molecular Adaptations of SARS-CoV-2 Spike Protein by Integrating Candidate Adaptive Polymorphisms with Protein Dynamics. Elife. 2024;12:RP92063. doi: 10.7554/eLife.92063.3.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.92063.3</ArticleId><ArticleId IdType="pmc">PMC11076047</ArticleId><ArticleId IdType="pubmed">38713502</ArticleId></ArticleIdList></Reference><Reference><Citation>Witte L., Baharani V.A., Schmidt F., Wang Z., Cho A., Raspe R., Guzman-Cardozo C., Muecksch F., Canis M., Park D.J., et al. Epistasis Lowers the Genetic Barrier to SARS-CoV-2 Neutralizing Antibody Escape. Nat. Commun. 2023;14:302. doi: 10.1038/s41467-023-35927-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-35927-0</ArticleId><ArticleId IdType="pmc">PMC9849103</ArticleId><ArticleId IdType="pubmed">36653360</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>